Double Trouble: The Challenge of Neuroprotection in Patients with Liver Cirrhosis and Atrial Fibrillation

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation

(2023) Tracey G. Simon et al.   Journal of the American Heart Association

Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study

(2023) Oluwadolapo D. Lawal et al.   CIRCULATION

Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis

(2023) Tong Hu et al.   American Journal of Cardiovascular Drugs

Management of Acute Coronary Syndrome in Patients with Liver Cirrhosis

(2021) Taha Ahmed et al.   American Journal of Cardiovascular Drugs

Transcatheter interventions for valvular heart diseases in liver cirrhosis patients

(2021) Taha Ahmed et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Liver Disease as a Predictor of New‐Onset Atrial Fibrillation

(2018) William A. Huang et al.   Journal of the American Heart Association

Cirrhosis is a risk factor for atrial fibrillation: A nationwide, population-based study

(2017) HyunJung Lee et al.   LIVER INTERNATIONAL

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

(2017) Ling Kuo et al.   Journal of the American Heart Association